// App-Quantinova.ai

: Dupilumab efficacy in asthma patients with comorbid chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST

Researchers

Presenter

  • Ian Douglas Pavord

Principal Investigators

  • Linda Ford

  • Lawrence Sher

  • Klaus F. Rabe

  • Hae-Sim Park

  • Borja G. Cosio

  • Meredith C. Foster

  • Heribert Staudinger

  • Jaman Maroni

  • Paul Rowe

  • Nikhil Amin

  • Gianluca Pirozzi

  • Marcella Ruddy

  • Bolanale Akinlade

  • Neil M.H. Graham

  • Ariel Teper

Medical Centers

  • Oxford Eye Hospital, University of Oxford, Oxford, United Kingdom

  • Asthma & Allergy Center, Bellevue, United States of America

  • Peninsula Research Associates, Rolling Hills Estates, CA, United States,

  • LungenClinic Großhansdorf and Christian Albrechts University Kiel, German Center for Lung Research (DZL), Kiel, Germany

  • Ewha Womans University Hospital, Seoul, Republic of Korea

  • Hospital Son Espases IdISBa-CIBERES, Palma de Mallorca, Spain

  • Sanofi US, Bridgewater, United States of America

  • Regeneron Pharmaceuticals - Tarrytown - United States of America

Locations

  • United Kingdom

  • United States

  • Germany

  • Republic of South Korea

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Twist-related protein 1

Drug/Treatment

  • Dupilumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • NCT02414854

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved